StonvexLoading…
StonvexStonvexStonvexCore line items from BHM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $19.70M | $68.14M | $49.23M | $32.62M |
Operating Income | $-10.22M | $-30.97M | $-21.75M | $-12.18M |
Net Income | $-10.30M | $-32.60M | $-23.12M | $-13.16M |
EPS (Diluted) | $-0.90 | $-3.02 | $-2.27 | $-1.33 |
Total Assets | $1.14B | $1.15B | $222.14M | $220.34M |
Total Liabilities | $448.40M | $462.56M | $2.78M | $2.56M |
Cash & Equivalents | $170.10M | $169.56M | $2.10M | $4.22M |
Free Cash Flow OCF − CapEx | $-12.30M | $10.40M | $14.59M | $5.88M |
Shares Outstanding | 3.90M | 3.89M | 3.89M | 3.88M |